Key barriers in adhering to anticoagulation guidelines included uncertainty about its choice, established practices, and the ...
The HYPERION study was evaluating Winrevair in recently diagnosed adults with pulmonary arterial hypertension.
New 20-year data show a survival rate of 90% with few repeat surgeries after this complex operation that can only be ...
During and after an exacerbation, mental recovery involves taking care of both your physical and mental health. Resting, ...
Tectonic Therapeutic, Inc.'s stock surged 120% on positive Phase 1b data for TX45 in treating PH-HFpEF, offering a potential ...
Merck (MRK) announced the Phase 3 HYPERION study evaluating WINREVAIR versus placebo in recently diagnosed adults with pulmonary arterial ...
TAG24 NEWS on MSN3m
Smokers beware: Chronic cough, shortness of breath could be COPDLong-term smokers often have a chronic cough. They may get used to it, and perhaps also to being winded after climbing stairs.But there are good reasons to take these symptoms seriously, as they can ...
Diag-Nose.io, a CDL-Seattle graduate, harnesses AI with RhinoMAPTM to redefine respiratory care, securing $2M in oversubscribed fundingSEATTLE, ...
Hosted on MSN17h
Lung Health in the Post-Pandemic World: Why It Becomes Even More Critical As You AgeWith the World Health Organization estimating that over 20 million people died from the coronavirus pandemic, despite ...
All patients in the trial will have the opportunity to resume or begin treatment with Winrevair, the company said.
A graduate of Stanford University's prestigious EENT Innovation Biodesign program in 2019, Diag-Nose.io is redefining ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback